Literature DB >> 3222761

Diminished activity of tartrate resistant acid phosphatase in alveolar macrophages from patients with active sarcoidosis.

J Barth1, H Kreipe, J Kiemle-Kallee, H J Radzun, M R Parwaresch, W Petermann.   

Abstract

Alveolar macrophages differ from their percursors in blood, monocytes, by expressing strong activity of the tartrate resistant variant of acid phosphatase (TAcP). A study was carried out to analyse the expression of this enzyme cytochemical marker by alveolar macrophages from bronchoalveolar lavage cells from 34 patients with sarcoidosis and 12 control subjects. Alveolar macrophages from control subjects displayed a strong and homogeneous staining pattern and only 0.1% of cells were negative after staining. Macrophages from patients with sarcoidosis showed reduced TAcP activity and up to 7% of the cells were negative. The percentage of TAcP negative macrophages was correlated with the percentage of lymphocytes and with the ratio of CD4 to CD8 lymphocytes among cells recovered by bronchoalveolar lavage. The reduced TAcP activity in alveolar macrophages from patients with sarcoidosis may be due to an increased recruitment of immature precursors from blood.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3222761      PMCID: PMC461553          DOI: 10.1136/thx.43.11.901

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  10 in total

Review 1.  Current concepts of the pathogenesis of sarcoidosis.

Authors:  P D Thomas; G W Hunninghake
Journal:  Am Rev Respir Dis       Date:  1987-03

2.  Monocytic origin of human alveolar macrophages.

Authors:  H J Radzun; M R Parwaresch; H Kreipe
Journal:  J Histochem Cytochem       Date:  1983-02       Impact factor: 2.479

3.  The macrophage as an effector cell.

Authors:  C F Nathan; H W Murray; Z A Cohn
Journal:  N Engl J Med       Date:  1980-09-11       Impact factor: 91.245

4.  Transient expression of type IV collagenolytic metalloproteinase by human mononuclear phagocytes.

Authors:  S Garbisa; M Ballin; D Daga-Gordini; G Fastelli; M Naturale; A Negro; G Semenzato; L A Liotta
Journal:  J Biol Chem       Date:  1986-02-15       Impact factor: 5.157

5.  Increased release of free oxygen radicals by phagocytosing and nonphagocytosing cells from patients with active pulmonary sarcoidosis as revealed by luminol-dependent chemiluminescence.

Authors:  J Barth; P Entzian; W Petermann
Journal:  Klin Wochenschr       Date:  1988-04-01

6.  Tartrate-resistant acid phosphatase as a differentiation marker for the human mononuclear phagocyte system.

Authors:  H J Radzun; H Kreipe; M R Parwaresch
Journal:  Hematol Oncol       Date:  1983 Oct-Dec       Impact factor: 5.271

7.  Alveolar macrophage replication. One mechanism for the expansion of the mononuclear phagocyte population in the chronically inflamed lung.

Authors:  P B Bitterman; L E Saltzman; S Adelberg; V J Ferrans; R G Crystal
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

8.  Characterization of mononuclear phagocyte subpopulations in the human lung by using monoclonal antibodies: changes in alveolar macrophage phenotype associated with pulmonary sarcoidosis.

Authors:  A J Hance; S Douches; R J Winchester; V J Ferrans; R G Crystal
Journal:  J Immunol       Date:  1985-01       Impact factor: 5.422

9.  Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity.

Authors:  G W Hunninghake; R G Crystal
Journal:  N Engl J Med       Date:  1981-08-20       Impact factor: 91.245

10.  Origin, Kinetics, and characteristics of pulmonary macrophages in the normal steady state.

Authors:  A B van oud Alblas; R van Furth
Journal:  J Exp Med       Date:  1979-06-01       Impact factor: 14.307

  10 in total
  6 in total

1.  Normal and sarcoid alveolar macrophages differ in their ability to present antigen and to cluster with autologous lymphocytes.

Authors:  V A Gant; Z Shakoor; I L Barbosa; A S Hamblin
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

2.  Increased expression of growth factor genes for macrophages and fibroblasts in bronchoalveolar lavage cells of a patient with pulmonary histiocytosis X.

Authors:  J Barth; H Kreipe; H J Radzun; K Heidorn; W Petermann; B Bewig; M R Parwaresch
Journal:  Thorax       Date:  1991-11       Impact factor: 9.139

3.  Phenotypic markers of alveolar macrophage maturation in pulmonary sarcoidosis.

Authors:  I Stríz; Y M Wang; H Teschler; C Sorg; U Costabel
Journal:  Lung       Date:  1993       Impact factor: 2.584

4.  Alveolar macrophages from bronchoalveolar lavage of patients with pulmonary histiocytosis X: determination of phenotypic and functional changes.

Authors:  M Uebelhoer; B Bewig; K Sternberg; K Rabe; D Nowak; H Magnussen; J Barth
Journal:  Lung       Date:  1995       Impact factor: 2.584

5.  Inhibitory effects of inhaled flunisolide on inflammatory functions of alveolar macrophages.

Authors:  B Bewig; J Barth
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

6.  Role of lysosomal enzymes released by alveolar macrophages in the pathogenesis of the acute phase of hypersensitivity pneumonitis.

Authors:  J L Pérez-Arellano; M N Barrios; T Martín; M L Sánchez; J M Buitrago; A Jiménez
Journal:  Mediators Inflamm       Date:  1995       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.